Bispecific antibody T cell therapy (GlycoNex)

N/A

Report date: 2024/06/05 14:40:04

Base Information

Drug NameBispecific antibody T cell therapy (GlycoNex)
Drug Alias NameArmed T cell therapy (GlycoNex)Bispecific Ab/ cell therapy (GlycoNex)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlyconex Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlyconex Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A